InventionMed S.A. (WSE:INM)

Poland flag Poland · Delayed Price · Currency is PLN
0.1710
+0.0005 (0.29%)
At close: Jul 16, 2025
-19.72%
Market Cap35.18M
Revenue (ttm)477.27K
Net Income (ttm)-4.49M
Shares Out202.79M
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume52,854
Average Volume144,116
Open0.1740
Previous Close0.1705
Day's Range0.1700 - 0.1740
52-Week Range0.1550 - 0.2350
Beta0.43
RSI46.28
Earnings DateAug 13, 2025

About InventionMed

InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. Its flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. The company also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology. InventionMed S.A. was incorporated in 2012 and is based in Bydgoszcz, Poland. [Read more]

Sector Healthcare
Founded 2012
Employees 5
Stock Exchange Warsaw Stock Exchange
Ticker Symbol INM
Full Company Profile

Financial Performance

In 2024, InventionMed's revenue was 277,760, an increase of 45810.74% compared to the previous year's 605. Losses were -4.41 million, 133.2% more than in 2023.

Financial Statements

News

There is no news available yet.